-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KQlWpp/bwvpGpJgKecqqcqjRYM0ncE8ErwByz/putoeV4RQkNmw37f9jpALk/H0N 4BLit1YY1mC3YoJ+62Wk8w== 0001178913-08-003107.txt : 20081203 0001178913-08-003107.hdr.sgml : 20081203 20081203155817 ACCESSION NUMBER: 0001178913-08-003107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081201 FILED AS OF DATE: 20081203 DATE AS OF CHANGE: 20081203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSMAN NACHUM CENTRAL INDEX KEY: 0001415890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31392 FILM NUMBER: 081227581 BUSINESS ADDRESS: BUSINESS PHONE: 927747107107 MAIL ADDRESS: STREET 1: FEINSTEIN 7 CITY: TEL AVIV STATE: L3 ZIP: 69123 FORMER NAME: FORMER CONFORMED NAME: ROZMAN NACHUM DATE OF NAME CHANGE: 20071023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC CENTRAL INDEX KEY: 0001158780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980351734 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 20 CITY: HAIFA STATE: L3 ZIP: 31905 BUSINESS PHONE: 972-4-850-1080 MAIL ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 20 CITY: HAIFA STATE: L3 ZIP: 31905 FORMER COMPANY: FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC DATE OF NAME CHANGE: 20030701 FORMER COMPANY: FORMER CONFORMED NAME: AI SOFTWARE INC DATE OF NAME CHANGE: 20010906 4 1 a86137_ex.xml X0303 4 2008-12-01 0 0001158780 PLURISTEM THERAPEUTICS INC PSTI 0001415890 ROSMAN NACHUM FEINSTEIN 7 TEL AVIV L3 69123 ISRAEL 1 0 0 0 Common Stock 2008-12-01 4 A 0 5500 A 5500 D The shares of common stock were issued to the reporting person in exchange for a voluntary reduction in the reporting person's cash compensation (reflecting a value of $ 0.40 per share of common stock). /s/ Nachum Rosman 2008-12-03 -----END PRIVACY-ENHANCED MESSAGE-----